Good morning, ladies and gentlemen, and welcome to the 2026 annual meeting of stockholders of OneMedNet Corporation. I am Aaron Green, Chief Executive Officer and member of the Board of Directors of the company. At the request of our Chairman, Dr. Jeffrey Yu, I will conduct the business of this meeting. We are excited about the future of the company, and we appreciate your attendance at this annual meeting, and most importantly, your support of OneMedNet. I now call the meeting to order. For your reference, the agenda and rules of conduct have been posted on the online annual meeting portal. We ask that you please follow these rules so we may have an orderly meeting. You may also submit written questions during the meeting and cast your vote on the online portal. Before we start the formal business of the meeting, I would like to introduce our directors and other executive officers joining us on the webcast annual meeting today. Present today are Dr. Jeffrey Yu, our Chairman of the Board and Chief Medical Officer, Andy Zeinfeld, a Director of the company, and Bob Golden, a Director and our Chief Financial Officer and Corporate Secretary. Mr. Golden will act as Secretary of the meeting. Al Burton, a representative of Continental Stock Transfer & Trust Company, has been appointed to act as Inspector of Election for this annual meeting. Alex Dundara, Thomas Orozco, representatives from our auditor, WithumSmith and Brown, PC, are also present today. They will be available to answer questions concerning the company's financial statements. As noted in the agenda today, we will conduct the official business of the annual meeting. During the meeting, we will attempt to answer questions that have been submitted by stockholders through the annual meeting portal that relate to the business of the meeting. Any other questions or any questions that are not answered can be addressed to our investor relations as specified in the rules of conduct. We will now proceed to the business portion of this meeting. As stated in the notice of meeting and proxy statement previously provided to you, the record date for voting at this meeting was the close of business on August 11th, 2026. The Secretary has delivered an affidavit of distribution to show that notice of this meeting was properly given. The Inspector of Election has examined the proxies received, and stockholders present at this meeting reports that more than 70% of the total shares of common stock entitled to vote at this meeting are represented at this meeting. Therefore, a quorum is present, and we will now proceed with the business. Please note that a list of stockholders as of the record date is available for inspection during the entire time of this annual meeting on the annual meeting website. The time now is 11:02 A.M. Central Time, and I declare the polls now open for each matter to be voted on at this meeting. All stockholders entitled to vote at this meeting have the ability to do so online. If you are a stockholder entitled to vote and have not yet voted, or if you want to change your previously cast vote, please do so via the online portal for this meeting. Please remember that if you have already voted by proxy, it is not necessary to vote again. After voting, this has been completed on all matters of the agenda, we will close the polls. There are four matters for consideration by stockholders at this meeting. The first matter to be voted upon is the election of three Class III directors nominated by our board of directors to serve three-year terms expiring at the 2029 annual meeting of stockholders. The nominees are Dr. Kenneth Alleyne, Sherry Coonse McCraw, and Dr. Jeffrey Yu. The board of directors recommends the election of each Dr. Kenneth Alleyne, Sherry Coonse McCraw, and Dr. Jeffrey Yu as Class III directors. The second item of business is the ratification of WithumSmith and Brown, PC as the company's independent registered public accounting firm for the year ending December 31st, 2026. The board of directors recommends that the stockholders approve this proposal. The third item of business is the approval of the OneMedNet Corporation Amended and Restated 2022 Equity Incentive Plan to increase the available share reserve by 1 million shares. The board of directors recommends that the stockholders approve this proposal. The fourth item of business is the approval of an amendment to our Third Amended and Restated Certificate of Incorporation, as amended to effect a reverse stock split of our common stock at a ratio ranging from any whole number between one for five and one for 20, as determined by the board of directors in its discretion. The board of directors recommends that the stockholders approve this proposal. Other business may be properly brought before this meeting by a stockholder only if timely notice in proper written form has been given in accordance with our bylaws and not withdrawn before the meeting. Other than the proposals discussed and set forth in the proxy materials, no other business will come before this meeting. I will now pause for a minute to allow for any questions on the matters to be voted upon at this meeting and allow for all stockholders to submit their votes. If you've not already done so, please vote by clicking on the voting button on the web portal and follow the instructions. Please also submit any questions related to the proposals now. Thank you. I declare the polls now closed at 11:06 A.M. Central Time and ask that the inspector of election collect and tabulate the votes. Based on the preliminary tabulations of the inspector of election, we announce that the company's Class III director nominees have been duly elected. The appointment of WithumSmith and Brown, PC as the company's independent registered public accounting firm for the year ending December 31st, 2026, has been ratified. The Amended and Restated 2022 Equity Incentive Plan to increase the available share reserve by 1 million shares has been approved, and the proposal to effect a reverse stock split of our common stock at a ratio ranging from any whole number between one for five and one for 20, as determined by the board of directors in its discretion, has been approved. Within four business days, the company will file a current report on Form 8-K with the SEC disclosing the final voting results for the matters voted on at this meeting. As there is no other formal business to be addressed, our program for the day has concluded, and I declare that the 2026 annual meeting of stockholders is hereby adjourned. Thank you all for attending today's meeting and for your continuing support of the company.